Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

about

Accurate Classification of NF1 Gene Variants in 84 Italian Patients with Neurofibromatosis Type 1.

P2860

Q52577514-DC9BB9AB-43AF-436D-8999-FC080319429F

P2860

Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

Item

http://www.wikidata.org/entity/Q47150280

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

@en

Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

@nl

type

Item

label

Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

@en

Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

@nl

prefLabel

Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

@en

Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

@nl

P1476

Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

@en

P2093

Alberto Velez Van Meerbeke

http://www.w3.org/2001/XMLSchema#string

Claudia Alejandra López Cabra

http://www.w3.org/2001/XMLSchema#string

Martha Milade Torres Nupan

http://www.w3.org/2001/XMLSchema#string

Paula Marcela Herrera Gomez

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning

Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis

The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1

Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.

Teaching reading to children with neurofibromatosis type 1: a clinical trial with random assignment to different approaches.

Neurocognitive profiles of learning disabled children with neurofibromatosis type 1

Methylphenidate in children with hyperactivity: review and cost-utility analysis.

P304

227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPED.2017.00227

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29164079

http://www.w3.org/2001/XMLSchema#string

P932

5670111

http://www.w3.org/2001/XMLSchema#string

Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

about

P2860

P2860

Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932